Gines, Pere

Publishing since 1983 (Dinosaur)

Has published 203 publications in 28 years

Number of publications published per year by Gines, Pere. (Source : PubMed)

Distribution of publications types for Gines, Pere. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Moreno M, Gonzalo T, Kok RJ, Sancho-Bru P, van Beuge M, Swart J, Prakash J, Temming K, Fondevila C, Beljaars L, Lacombe M, van der Hoeven P, Arroyo V, Poelstra K, Brenner DA, Ginès P, Bataller R. Reduction of advanced liver fibrosis by short-term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats.  Hepatology  2010;51;3  
•  Moreno M, Chaves JF, Sancho-Bru P, Ramalho F, Ramalho LN, Mansego ML, Ivorra C, Dominguez M, Conde L, Millán C, Marí M, Colmenero J, Lozano JJ, Jares P, Vidal J, Forns X, Arroyo V, Caballería J, Ginès P, Bataller R. Ghrelin attenuates hepatocellular injury and liver fibrogenesis in rodents and influences fibrosis progression in humans.  Hepatology  2010;51;3  
•  Ginès P, Wong F, Watson H, Terg R, Bruha R, Zarski JP. Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatremia - a randomized, double-blind, placebo-controlled study.  Aliment. Pharmacol. Ther.  2010  
•  Sancho-Bru P, Juez E, Moreno M, Khurdayan V, Morales-Ruiz M, Colmenero J, Arroyo V, Brenner DA, Ginès P, Bataller R. Hepatocarcinoma cells stimulate the growth, migration and expression of pro-angiogenic genes in human hepatic stellate cells.  Liver Int.  2010;30;1  
•  Nazar A, Pereira GH, Guevara M, Martín-Llahi M, Pepin MN, Marinelli M, Solá E, Baccaro ME, Terra C, Arroyo V, Ginès P. Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome.  Hepatology  2010;51;1  
•  Cárdenas A, Ginès P. A patient with cirrhosis and increasing creatinine level: what is it and what to do?  Clin. Gastroenterol. Hepatol.  2009;7;12  
•  Charlton MR, Wall WJ, Ojo AO, Ginès P, Textor S, Shihab FS, Marotta P, Cantarovich M, Eason JD, Wiesner RH, Ramsay MA, Garcia-Valdecasas JC, Neuberger JM, Feng S, Davis CL, Gonwa TA. Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation.  Liver Transpl.  2009;15;11  
•  Ginès P, Schrier RW. Renal failure in cirrhosis.  N. Engl. J. Med.  2009;361;13  
•  Colmenero J, Bataller R, Sancho-Bru P, Dominguez M, Moreno M, Forns X, Bruguera M, Arroyo V, Brenner DA, Ginès P. Effects of Losartan on Hepatic Expression of Non-phagocytic NADPH Oxidase and Fibrogenic Genes in Patients with Chronic Hepatitis C.  Am. J. Physiol. Gastrointest. Liver Physiol.  2009  
•  Balderramo DC, García O, Colmenero J, Espinosa G, Forns X, Ginès P. Antiphospholipid syndrome during pegylated interferon alpha-2a therapy for chronic hepatitis C.  Dig Liver Dis  2009;41;7  

[ See timeline ] [ See all publications ]